Dennis J. Selkoe, MD.
The Vincent and Stella Coates Professor of Neurologic Diseases 
Harvard Medical School&
Co-Director, Ann Romney Center for Neurologic Diseases                         
Brigham and Women's Hospital
Boston MA, USA
Title: Molecular Elucidation of Alzheimer’s and Parkinson’s Diseases Predicts Novel Therapies

Tod Woolf, PhD.                                                                  
Chief Executive Officer
Etagen Pharma Inc.
Cambridge, MA, USA
Title: Chemically-modified polynucleotides for inhibiting, expressing and repairing nucleic acids

Mark W. Feinberg, MD.
Associate Professor of Medicine
Brigham and Women's Hospital/Harvard Medical School
Boston, MA, USA
Title: MicroRNA-mediated control of glucose homeostasis and insulin resistance

Michael Strano, PhD.
Professorof Chemical Engg.
Massachusetts Institute of Technology
Cambridge, MA, USA
Title: Emerging applications of carbon nanosensortechnology to precision medicine

 Kexian Zhu, PhD. candidate
Stem Cell and Regenerative Biology
Harvard University
Cambridge, MA, USA
Title: Gene editing in dystrophic mouse muscle and muscle stem cells

Gerald Marsischky, PhD. 
Director, Genome Engineering Production Group
Harvard Medical School
Boston MA, USA
Title:CRISPR/Cas9-based genome editing strategies in Drosophila, Human cells and mouse germlines

Dongming Cai, MD, PhD.
Assistant Professor of Neurology
Icahn (Mount Sinai) School Of Medicine 
New York, NY, USA
Title: Apo-E4 associated Alzheimer disease pathogenesis

Dianne Hoffman-Kim, PhD.
Associate Professor of Medical Science
Brown Inst for Neuroscience
Brown University
Providence, RI, USA
Title: 3D Neural Spheroid Culture: An In Vitro Model for Cortical Studies

Victor Dillard                                    
Chief Operating officer
Desktop Genetics Ltd.
London, United
Title: Bioinformatic tools to design genome editing experiments using CRISPR/Cas9 system Kingdom

Jonathan P. Newman, PhD.
ostdoctoral Fellow
Massachusetts Institute of Technology
Cambridge, MA, USA
Title:Real-time optical feedback to control and study neural dynamics

Cheryl H. Cui, PhD. candidate
Harvard-MIT Div. of Health Sci. & Tech.
Massachusetts Institute of Technology
Cambridge, MA, USA
Title: Massively parallel combinatorial genetic perturbation screening with CRISPR-Cas9 in human cells

Oleg A. Sineshchekov, PhD.
Research Professor of Biochemistry
Univ. of Texas Health Science Center
Houston TX,USA
Title: Anion channelrhodopsins from cryptophyte algae as new efficient tools for inhibitory optogenetics

Yvonne Tay, PhD.
Assistant Professorof Biochemistry
Yong Lo Lin School of Medicine
National University of Singapore, Singapore
Title: MicroRNA-638 regulates iron metabolism in prostate cancer

Alexander Serganov, Ph.D.
Assistant Professor of Biochemistry
New York University School of Medicine
New York, NY, USA
Title: Role of RNA-protein interactions in gene expression control 

Raffaella Sordella, PhD.
Associate Professor
Cold Spring Harbor Laboratory Cancer Center
Cold Spring Harbor, NY, USA
Title: CRISPR-based Genome Editing

Amar Sahay, PhD.
Assistant Professor of Psychiatry
Harvard’s Massachusetts General Hospital, Boston, MA, USA
Title: Adult hippocampal neurogenesis and fear generalization

Miguel A. Moreno-Mateos PhD.
Associate Research Scientist in Genetics
Yale University School of Medicine
New Haven, CT, USA
Title: Applying an optimized CRISPR/Cas9 system to uncover genes involved in brain development

Tomas J. Ryan, PhD.     
HHMI Research Specialist
Picower INST. for Learning and Memory
Massachusetts Institute of Technology
Cambridge, MA, USA
Title: Precise manipulation of memory using engram cell technology

Chengyu Jiang, PhD.
Professor of Biochemistry
Peking Union Medical College&CAS
Beijing, P.R. China
Title: MicroRNAs role in Ebola virus infection

Padmanabh (Pad) Chivukula PhD.
Founder & Chief Scientific Officer
Arcturus Therapeutics, Inc.
San Diego, CA, USA
Title: TBA

Bruno Combettes, PhD.                              
Business Development Manager EMEA
Andor technology PLC.
Belfast, United Kingdom
Title: TBA

James L. Sherley, MD., PhD.
Director Asymmetrex, LLC.
Boston, MA, USA
Title: Bringing precision to gene-editing therapeutics by counting hematopoietic stem cells

Richie Kohman, PhD.          
Biomaterials Engineer& Group Leader
Expansion Technologies Inc.
Cambridge, MA, USA
Title: Light-initiated release of neurotransmitters from DNA nanostructures

Dong-ki Lee, Ph. D.                          
Professor of Chemistry
Sungkyunkwan University, Suwon,&
Founder and CEO
OliX Pharmaceuticals, Seoul, SouthKorea
Title:TBA

Xue Jun (June) Li, PhD.
Associate Professorof Biomedical Sciences
University of Illinois
Rockford, IL, USA
Title: Elucidating the degeneration of spinal motor neurons in human models of spinal muscular atrophy

Andrew Grimson, PhD.
Assistant Professor of Molecular Biology and Genetics
Cornell University,
Ithaca, NY, USA
Title: Fetal and adult progenitors give rise to unique populations of CD8+ T cells

Jiannis Ragoussis, PhD.
Professor and Head of Genome Sciences
McGill University
Montréal, Québec, Canada
Title: Comprehensive mir-210 target identification reveals new prognostic markers in breast cancer

Junjun Shi, PhD.
Assistant Professor of Anesthesia
Brigham and Women’s Hospital
Boston MA, USA,
Title: RNAi Nanotechnology for cancer target validation and therapy

Leonid A. Pobezinsky, PhD.
Assistant Professor of Vet. & Animal Sciences, University of Massachusetts
Amherst, MA, USA
Title: Regulatory role of non-coding RNAs in immune responses

Dong-Wook Kim (DW Kim), PhD.
Professor of Physiology
Yonsei University College of Medicine
Seoul, South Korea 
Title: Genome Editing of Structural Variations in Patient-derived iPS Cells